DR ANTHONY MELVIN CRASTO,WorldDrugTracker, helping millions, A 90 % paralysed man in action for you, I am suffering from transverse mylitis and bound to a wheel chair, With death on the horizon, nothing will not stop me except God................DR ANTHONY MELVIN CRASTO Ph.D ( ICT, Mumbai) , INDIA 25Yrs Exp. in the feld of Organic Chemistry,Working for GLENMARK GENERICS at Navi Mumbai, INDIA. Serving chemists around the world. Helping them with websites on Chemistry.Million hits on google, world acclamation from industry, academia, drug authorities for websites, blogs and educational contribution

Tuesday 12 August 2014

5-(Cyclopropylmethyl)-1,3,4-thiadiazol-2-amine

5-(Cyclopropylmethyl)-1,3,4-thiadiazol-2-amine



Figure US20020052370A1-20020502-C00126

Oxalyl chloride (3.13 ml, 35.9 mmol) and N,N-dimethylformamide (1 drop) were added to a solution of cyclopropylacetic acid (3 g, 29.9 mmol) in dichloromethane (30 ml), and the reaction stirred at room temperature for 18 hours. The mixture was concentrated under reduced pressure and azeotroped with dichloromethane to give a brown oil. A mixture of this intermediate acid chloride (887 mg, 7.48 mmol) and thiosemicarbazide (455 mg, 4.99 mmol) were heated at 70° C. for 18 hours, then cooled. Water was added, the mixture basified to pH 9 using 50% aqueous sodium hydroxide solution, and the resulting precipitate filtered and dried, to give the title product, 410 mg, 53%; 


1H NMR (CD3OD, 400 MHz) δ: 0.28 (m, 2H), 0.60 (m, 2H), 1.02 (m, 1H), 2.77 (d, 2H); 


LRMS: m/z 155.2 (MH+).

No comments:

Post a Comment